Mikael Elias and his research group are developing enzymes that can safeguard corn plants from a bacterial infection with no known cure.

Mikael Elias shares his vision for bridging the gap between scientific discovery and market application.

Unique collaboration yields a much-needed common language for genetic biocontrol technology development.

Graduate student Christopher Belica is developing tools to inhibit APOBEC3B, an enzyme linked to cancer adaptation and treatment resistance.